Page 42 - Technology Startups News Today : Breaking News, Live Updates & Top Stories | Vimarsana

London received quarter of all European tech funding in 2020 Technology startups in London raised near-record levels of venture capital investment last year despite uncertainty related to Brexit and Covid-19 Share this item with your network: By Published: 14 Jan 2021 14:29 London-based technology startups received $10.5bn of venture capital (VC) investment in 2020, accounting for a quarter of all European tech funding, new research has revealed. The research, conducted by market intelligence firm Dealroom and investment agency London & Partners, shows that a significant chunk of the inv...

ONL Therapeutics, Inc., an Ann Arbor, Mich.-based biopharmaceutical company developing novel therapies for protecting the vision of patients with retinal disease, closed on $46.9m in a Series B financing round. The round included new investors Bios Partners, which led the round, Johnson & Johnson Innovation – JJDC, Inc., Kaitai Capital, PSQ Capital, and Michigan Capital Network Venture Fund III. Existing investors that participated in the round include ONL Therapeutics management, InFocus Capital Partners, ExSight Ventures, the University of Michigan’s Michigan Investment in New Technolo...

Ann Arbor eye-drug developer ONL Therapeutics raises $47 million in latest venture capital round Studies to expand into areas such as glaucoma Funding comes from mix of new and existing investors Getty Images/iStockphoto Ann Arbor-based pharmaceutical company ONL Therapeutics Inc. has closed on nearly $47 million in a Series B fundraising round that will further the company's work on developing drugs to protect against several eye conditions that cause blindness. The investment was led by Fort Worth, Texas-based venture capital firm Bios Partners, with participation from several other new inv...

ONL Therapeutics Closes $46.9 Million in Series B Financing to Advance ONL1204 into Three Retinal Disease Indications Beyond retinal detachment, lead candidate ONL1204 will also advance into the chronic conditions of glaucoma and dry age-related macular degeneration over the next 24 months December 22, 2020 07:00 ET | Source: ONL Therapeutics ONL Therapeutics Ann Arbor, Michigan, UNITED STATES ANN ARBOR, Mich., Dec. 22, 2020 (GLOBE NEWSWIRE) -- ONL Therapeutics, Inc., a biopharmaceutical company developing novel therapies for protectin...

Advertisement CEMEX Ventures, CEMEX’s Corporate Venture Capital and Open Innovation unit, has unveiled its TOP50 ConTech Startups list, which includes the 50 most promising new solutions from the 2020 construction ecosystem and the cities of the future. The investment ecosystem in construction startups gets traction and closes the year 2020, surpassing US$1.3 billion of investment in startups, the previous record dates from 2018 with more than US$1.8 billion invested. Also, it is the fourth consecutive year in which the number of financing rounds exceeds 100. In 2020, CEMEX Ventures is one ...